News
Sanofi should hear from the FDA in September about its filing for Sarclisa as a first-line therapy for multiple myeloma after a priority review.
Yahoo Finance is chronicling the latest news and updates on Trump's tariffs.
Yahoo Finance is chronicling the latest news and updates on Trump's tariffs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback